These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 12955020)

  • 21. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
    Pasquino AM; Pucarelli I; Roggini M; Segni M
    J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationships between puberty and growth at adolescence in growth-hormone-deficient males: effect of growth hormone and of associated gonadal suppression therapy.
    Tanaka T; Yoshizawa A; Tanae A; Hibi I; Shizume K
    Horm Res; 1990; 33 Suppl 4():102-5. PubMed ID: 2147164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia.
    Quintos JB; Vogiatzi MG; Harbison MD; New MI
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1511-7. PubMed ID: 11297576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined use of growth hormone and gonadotropin-releasing hormone analogues in precocious puberty: theoretic and practical considerations.
    Walvoord EC; Pescovitz OH
    Pediatrics; 1999 Oct; 104(4 Pt 2):1010-4. PubMed ID: 10506253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of gonadotrophin releasing hormone analogue on height prognosis in growth hormone deficiency and normal puberty.
    Stanhope R; Brook CG
    Eur J Pediatr; 1988 Dec; 148(3):200-2. PubMed ID: 3145878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined therapy with luteinizing hormone releasing hormone agonist (LHRHa) and growth hormone (GH) in central precocious puberty.
    Volta C; Regazzi C; Ndaka J; Vitale R; Bernasconi S
    Acta Biomed; 2005 Sep; 76(2):73-8. PubMed ID: 16350551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth in precocious puberty.
    Brown JJ; Warne GL
    Indian J Pediatr; 2006 Jan; 73(1):81-8. PubMed ID: 16444068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Idiopathic short stature.
    Pasquino AM; Albanese A; Bozzola M; Butler GE; Buzi F; Cherubini V; Chiarelli F; Cavallo L; Drop SL; Stanhope R; Kelnar CJ;
    J Pediatr Endocrinol Metab; 2001 Jul; 14 Suppl 2():967-74. PubMed ID: 11529403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aromatase inhibitors in men: effects and therapeutic options.
    de Ronde W; de Jong FH
    Reprod Biol Endocrinol; 2011 Jun; 9():93. PubMed ID: 21693046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Near-final height in 82 Chinese patients with congenital adrenal hyperplasia due to classic 21-hydroxylase deficiency: a single-center study from China.
    Juan L; Huamei M; Zhe S; Yanhong L; Hongshan C; Qiuli C; Jun Z; Song G; Minlian D
    J Pediatr Endocrinol Metab; 2016 Jul; 29(7):841-8. PubMed ID: 27054598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gonadotropin releasing hormone analogue therapy in children with isolated growth hormone deficiency: final height benefit from postponing puberty?
    Bocca G; Bruin N; Delemarre-van de Waal HA
    J Pediatr Endocrinol Metab; 2005 Jun; 18(6):535-9. PubMed ID: 16042319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Should the dose of growth hormone be increased during the growth spurt of children with isolated growth hormone deficiency?
    Papagianni M; Stanhope R
    J Pediatr Endocrinol Metab; 2003; 16(8):1095-7. PubMed ID: 14594167
    [No Abstract]   [Full Text] [Related]  

  • 34. Pubertal disorders and bone maturation.
    Lazar L; Phillip M
    Endocrinol Metab Clin North Am; 2012 Dec; 41(4):805-25. PubMed ID: 23099272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Use of Gonadotropin-Releasing Hormone Analogs beyond Precocious Puberty.
    Eugster EA
    J Pediatr; 2015 Aug; 167(2):481-5. PubMed ID: 26073104
    [No Abstract]   [Full Text] [Related]  

  • 36. Optimizing growth hormone therapy during puberty.
    Codner E; Mericq V; Cassorla F
    Horm Res; 1997; 48 Suppl 5():16-20. PubMed ID: 9434040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W; Briody J; Moore B; Lu PW; Cowell CT
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological management of children with short stature: the role of aromatase inhibitors.
    Damiani D; Damiani D
    J Pediatr (Rio J); 2007 Nov; 83(5 Suppl):S172-7. PubMed ID: 17901908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?
    Colmenares A; González L; Gunczler P; Lanes R
    J Pediatr Endocrinol Metab; 2012; 25(7-8):651-7. PubMed ID: 23155689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adult height in short normal adolescent girls treated with gonadotropin-releasing hormone analog and growth hormone.
    Balducci R; Toscano V; Mangiantini A; Municchi G; Vaccaro F; Picone S; Di Rito A; Boscherini B
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3596-600. PubMed ID: 8530605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.